Thrivent Financial for Lutherans’s Agios Pharmaceuticals AGIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-17,526	Closed	-$583K	–	2366
2025 Q2	$583K	Hold	17,526	–	–	﹤0.01%	2069
2025 Q1	$514K	Hold	17,526	–	–	﹤0.01%	2059
2024 Q4	$576K	Sell	17,526 -7,077	-29%	-$332K	﹤0.01%	2192
2024 Q3	$1.09M	Hold	24,603	–	–	﹤0.01%	1859
2024 Q2	$1.06M	Sell	24,603 -1,051	-4%	-$37.9K	﹤0.01%	1833
2024 Q1	$750K	Hold	25,654	–	–	﹤0.01%	2052
2023 Q4	$572K	Sell	25,654 -19,151	-43%	-$429K	﹤0.01%	2154
2023 Q3	$1.11M	Buy	44,805 +22	+0%	+$582	﹤0.01%	1672
2023 Q2	$1.27M	Sell	44,783 -2,196	-5%	-$54.6K	﹤0.01%	1646
2023 Q1	$1.08M	Hold	46,979	–	–	﹤0.01%	1744
2022 Q4	$1.32M	Sell	46,979 -564	-1%	-$15.9K	﹤0.01%	1551
2022 Q3	$1.34M	Sell	47,543 -55,776	-54%	-$1.5M	﹤0.01%	1483
2022 Q2	$2.29M	Buy	+103,319	New	+$2.33M	0.01%	1152
2021 Q1	–	Sell	-350,768	Closed	-$15.2M	–	2521
2020 Q4	$15.2M	Buy	350,768 +86,829	+33%	+$3.43M	0.04%	521
2020 Q3	$9.24M	Sell	263,939 -7,119	-3%	-$312K	0.02%	623
2020 Q2	$14.5M	Buy	271,058 +1,387	+0.5%	+$64.2K	0.04%	451
2020 Q1	$9.57M	Buy	269,671 +938	+0.3%	+$43.3K	0.03%	508
2019 Q4	$12.8M	Buy	268,733 +28,944	+12%	+$1.09M	0.04%	507
2019 Q3	$7.77M	Buy	+239,789	New	+$9.93M	0.02%	568